Literature DB >> 1591233

The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism. Insights from studies with transgenic mice.

K R Marotti1, C K Castle, R W Murray, E F Rehberg, H G Polites, G W Melchior.   

Abstract

To assess the effects of cholesteryl ester transfer protein (CETP) on the primate lipoprotein profile, a transgenic mouse expressing cynomolgus monkey CETP was developed. The C57BL/6 mouse was used, and four lines expressing the primate CETP were established. The level of CETP activity in the plasma of the transgenic mice ranged from values similar to those obtained for the monkey to levels approximately sixfold higher than that in the normal monkey. When all of the lines were taken into consideration, there was a strong (r = -0.81 or higher, p less than 0.01) negative correlation between plasma CETP activity and total plasma cholesterol, plasma apolipoprotein (apo) A-I levels, and plasma apo A-I to apo B ratio. There was a strong positive correlation (r = 0.77) between plasma CETP activity and plasma apo B levels. The size of the apo A-I-containing lipoproteins was significantly reduced in mice with high plasma CETP activity, and that reduction in size was due to the absence of the larger (HDL1 and HDL2) apo A-I-containing particles in the plasma. When the transgenic mice were fed a high-fat, high-cholesterol diet, the effects of the diet on lipoprotein profile were more prominent in the CETP transgenic mice than the controls. The CETP transgenic mice had, for example, substantially higher plasma cholesterol and plasma apo B levels (p less than 0.01), and the apo B-containing lipoproteins were generally larger than those in the nontransgenic C57BL/6 mice consuming the same diet.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591233     DOI: 10.1161/01.atv.12.6.736

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  24 in total

1.  Biochemical characterization of cholesteryl ester transfer protein inhibitors.

Authors:  Mollie Ranalletta; Kathleen K Bierilo; Ying Chen; Denise Milot; Qing Chen; Elaine Tung; Caroline Houde; Nadine H Elowe; Margarita Garcia-Calvo; Gene Porter; Suzanne Eveland; Betsy Frantz-Wattley; Mike Kavana; George Addona; Peter Sinclair; Carl Sparrow; Edward A O'Neill; Ken S Koblan; Ayesha Sitlani; Brian Hubbard; Timothy S Fisher
Journal:  J Lipid Res       Date:  2010-05-10       Impact factor: 5.922

2.  Cholesteryl ester transfer protein alters liver and plasma triglyceride metabolism through two liver networks in female mice.

Authors:  Brian T Palmisano; Thao D Le; Lin Zhu; Yoon Kwang Lee; John M Stafford
Journal:  J Lipid Res       Date:  2016-06-27       Impact factor: 5.922

3.  Obesity and altered glucose metabolism impact HDL composition in CETP transgenic mice: a role for ovarian hormones.

Authors:  Melissa N Martinez; Christopher H Emfinger; Matthew Overton; Salisha Hill; Tara S Ramaswamy; David A Cappel; Ke Wu; Sergio Fazio; W Hayes McDonald; David L Hachey; David L Tabb; John M Stafford
Journal:  J Lipid Res       Date:  2012-01-03       Impact factor: 5.922

Review 4.  Hyperlipidaemia and cardioprotection: Animal models for translational studies.

Authors:  Ioanna Andreadou; Rainer Schulz; Lina Badimon; Adriana Adameová; Petra Kleinbongard; Sandrine Lecour; Panagiota-Efstathia Nikolaou; Ines Falcão-Pires; Gemma Vilahur; Nicholas Woudberg; Gerd Heusch; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

5.  Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided Approach.

Authors:  Jonathan E Wilson; Ravi Kurukulasuriya; Mikhail Reibarkh; Maud Reiter; Aaron Zwicker; Kake Zhao; Fengqi Zhang; Rajan Anand; Vincent J Colandrea; Anne-Marie Cumiskey; Alejandro Crespo; Ruth A Duffy; Beth Ann Murphy; Kaushik Mitra; Douglas G Johns; Joseph L Duffy; Petr Vachal
Journal:  ACS Med Chem Lett       Date:  2016-01-04       Impact factor: 4.345

6.  The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance.

Authors:  Melinde Wijers; Paolo Zanoni; Nalan Liv; Dyonne Y Vos; Michelle Y Jäckstein; Marieke Smit; Sanne Wilbrink; Justina C Wolters; Ydwine T van der Veen; Nicolette Huijkman; Daphne Dekker; Niels Kloosterhuis; Theo H van Dijk; Daniel D Billadeau; Folkert Kuipers; Judith Klumperman; Arnold von Eckardstein; Jan Albert Kuivenhoven; Bart van de Sluis
Journal:  JCI Insight       Date:  2019-06-06

7.  Cholesteryl ester transfer protein protects against insulin resistance in obese female mice.

Authors:  David A Cappel; Brian T Palmisano; Christopher H Emfinger; Melissa N Martinez; Owen P McGuinness; John M Stafford
Journal:  Mol Metab       Date:  2013-09-02       Impact factor: 7.422

8.  Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior.

Authors:  K Aalto-Setälä; C L Bisgaier; A Ho; K A Kieft; M G Traber; H J Kayden; R Ramakrishnan; A Walsh; A D Essenburg; J L Breslow
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

9.  Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.

Authors:  C Pászty; N Maeda; J Verstuyft; E M Rubin
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

10.  Cholesteryl ester transfer protein inhibition by PD 140195.

Authors:  C L Bisgaier; A D Essenburg; L L Minton; R Homan; C J Blankley; A White
Journal:  Lipids       Date:  1994-12       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.